Robert Seminara, head of Europe at Apollo Global Management, has reported a noticeable rise in private equity deal activity, and is forecasting attractive returns for investors entering the market now, according to a report by Bloomberg.
Law firm Cahill Gordon & Reindel LLP has appointed Dan Amato as a Partner in the firm’s private credit practice in New York. Amato joins from Orrick, Herrington & Sutcliffe LLP where he served as a Partner and Head of Sponsor Finance.
Intermediate Capital Group Plc (ICG), the €101bn London-headquartered private equity firm, has secured €15.2bn ($16.8bn) for its latest European direct-lending fund, making it the largest fund of its kind in the region, according to a report by Bloomberg.
US private equity major TPG is in discussions to acquire a stake in Europe’s largest second-hand fashion platform, Vinted, at a valuation of €5bn following rapid expansion at the Lithuanian company, according to a report by the Financial Times.
BEX Capital, a private investment firm focused exclusively on secondaries in private equity fund-of-funds (FoF), secondaries funds and co-investment funds, has held the final close of BEX Fund V at its target of $765m in capital commitments.
Global private equity firm Permira’s Growth Opportunities II, fund has acquired a majority stake in BioCatch, a specialist in digital fraud detection and financial crime prevention powered by behavioural biometric intelligence.
FalconPoint Partners (FalconPoint), a private equity firm focused on investing in North American middle market companies in the business services and industrial sectors, has appointed Adam Gross as Partner, Head of Business Development and Capital Markets.
CIL, the growth strategy consulting firm with offices in the US, Europe, and the UK, has hired Frédéric Thomas as Partner to lead its French operations, and be part of its Global Healthcare & Life Sciences practice.
Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on investments in the healthcare sector, has appointed Michael Keaveney as a Partner and Head of Investor Relations.
Bain Capital and Parthenon Capital are in discussions to sell a minority stake in healthcare technology company Zelis in a deal that could value the firm at around $17bn, according to a report by Bloomberg.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
